ImmunoGen Gets Positive Data on New Drug

Monday, 26 Sep 2011 | 6:48 PM ET

In this volatile market, investors need stocks that will keep them interested even when things are at their most bleak, says Mad Money host, Jim Cramer. Discussing the next-generation of cancer treatments with biotech developer, Daniel Julies, ImmunoGen CEO.